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Introduction
Systemic lupus erythematosus (SLE) is an autoim-
mune disease which manifests with the loss of tol-
erance for self-antigens and the production of auto-
antibodies. Autoantibodies form immune complexes 
which accumulate in different organs, leading to in-
flammation and damage. Systemic lupus erythema-
tosus in 50-80% of cases involves the kidney, causing 
lupus nephritis (LN), mainly in the form of glomeru-
lonephritis. Glomerular inflammation is followed by 
the activation of tubular epithelial cells, interstitial 
fibrosis and eventual renal failure [1].
Glomerular lesions in SLE are classified by the In-
ternational Society of Nephrology/Renal Pathology 
Society (ISN/RPS) system or the older World Health 
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Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus; 
in LN class IV morphologic lesions may be similar to the lesions in primary mem-
branoproliferative glomerulonephritis (MPGN). The aim of the study was to com-
pare the counts of tryptase-positive and chymase-positive mast cells between LN 
class IV and MPGN. 
The material consisted of 61 renal biopsies: 32 with lupus nephritis class IV, and  
29 with membranoproliferative glomerulonephritis. Chymase- and tryptase-posi-
tive cells were stained by immunohistochemistry and subsequently counted. 
The mean count of chymase-positive mast cells was 21.94 for the whole group, 
12.66 for LN class IV and 32.18 for MPGN. The mean count of tryptase-pos-
itive cells was 34.94 hpf for the entire group, 22.98 for LN class IV and 48. 
13 for MPGN. The differences between lupus nephritis and membranoprolifera-
tive glomerulonephritis were significant both for chymase- and tryptase-positive 
cells. Both chymase-positive MC counts and tryptase-positive MC counts correlat-
ed with relative interstitial volume (RIV) (R = 0.35 and R = 0.28, respectively) 
and with creatinine level (R = 0.35 and R = 0.43, respectively). There was also 
a significant correlation between age, creatinine level and RIV (R = 0.28 and  
R = 0.26, respectively).
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Organization (WHO) system; LN is divided into six 
classes with different mesangial, endothelial and ep-
ithelial injury patterns. Systemic lupus erythemato-
sus class IV, also called diffuse lupus nephritis, is an 
endo- or extracapillary glomerulonephritis with dif-
fuse subendothelial immune deposits, with or with-
out mesangial alterations, which can be segmental or 
global [2].
Membranoproliferative glomerulonephritis (MPGN) 
is a rare renal disease characterized by diffuse mesangial 
cell proliferation, along with structural changes in glo-
merular capillary walls, specifically subendothelial and 
subepithelial deposits [3, 4]. This pattern is similar to 
that seen in lupus nephritis ISN/RPS class IV. Mem-
branoproliferative glomerulonephritis can be divided 
into types I, II (dense deposit disease (DDD)) and III. 
The relationship between these three subtypes remains 
uncertain, but DDD is generally regarded as distinct, 
whereas types I and III are regarded as related entities. 
Types II and III are rare, while type I shows the highest 
morphologic similarity to proliferative lupus nephritis; 
thus from this point onwards, if not otherwise speci-
fied, the term MPGN refers to type I only [5].
Mast cells (MCs) are bone marrow-derived cells 
well known for their contribution to anaphylactic 
reactions, where they induce inflammation by releas-
ing a range of mediators [6]. They are also known to 
participate in renal interstitial inflammation, where 
they contribute to renal fibrosis [7, 8]. Human mast 
cells contain granules with two proteases – chymase 
and tryptase. Mast cells can be divided into two 
classes, chymase-positive and chymase-negative, 
due to the fact that only a portion of mast cells are 
positive for chymase [9-11]. Chymase has the abili-
ty to convert angiotensin I to angiotensin II, which 
regulates intrarenal blood flow, and also participates 
in renal interstitial fibrosis [11, 12]. It is involved 
in renal remodeling by increasing the expression of 
transforming growth factor β (TGF-β) [13]. Trypt-
ase is a serine protease expressed almost exclusively 
in mast cells. It has many biological functions, such 
as its role as a mitogen for fibroblasts, smooth mus-
cle cells and bronchial epithelial cells. Additionally, 
it has been shown that tryptase participates in skin, 
lung and renal fibrosis by promoting the prolifera-
tion of fibroblasts and the production of extracellular 
matrix [14]. It is also known for its contribution to 
acute renal transplant rejection and chronic allograft 
nephropathy [15].
The aim of the study was to compare the counts 
of chymase-positive and tryptase-positive mast cells 
in LN ISN/RPS class IV and MPGN, two different 
diseases with similar morphologic changes. We ex-
amined the relationship between mast cell interstitial 
infiltration, renal function and diagnosis.
Material and methods
The material consisted of 61 renal biopsies from 
32 patients with LN and 29 patients with MPGN, 
collected from the archives of the Department of 
Pathomorphology (Collegium Medicum, Jagiellonian 
University, Krakow). Only representative biopsies 
were used for this study.
The material was fixed in formalin, processed by 
the routine method and embedded in paraffin. 4 μm 
sections were cut from paraffin blocks. Sections were 
stained with standard hematoxylin and eosin, peri-
odic acid-Schiff, Masson’s trichrome, Congo red, and 
Jones’ silver methods for histologic classification. 
Primary anti-tryptase antibody (1 : 100; Leica 
Biosystems GmbH, Wetzlar, Germany) and anti- 
chymase antibody (1 : 100; Abcam, Cambridge, UK) 
were used. The immunohistochemistry was performed 
according to the routine manual method. The Lab 
Vision detection system (Thermo Fisher Scientific, 
Waltham, MA, USA) was used with 3-amino-9-eth-
ylcarbazole as the chromogen. The slides were coun-
Fig. 1. Chymase positive cells in renal interstitium. Immu-
nohistochemistry, original magnification 400×
Fig. 2. Tryptase positive cells in renal interstitium. Immu-
nohistochemistry, original magnification 400×
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terstained with Mayer hematoxylin (Thermo Fisher 
Scientific) and coverslipped. The immunostained slides 
were examined on an Olympus CH20 optical micro-
scope equipped with a 40× lens; the number of im-
munopositive cells and the number of fields of view 
were documented. The results were expressed as the 
sum of positive cells from 10 high power fields, while 
the area of one high power field was 0.159 mm2. The 
person performing the assessment was aware of neither 
the clinical data nor the diagnoses. The values of serum 
creatinine and daily proteinuria were obtained from the 
patients’ records.
For the assessment of relative interstitial volume 
(RIV), Masson’s trichrome stained sections were used 
with a Zeiss Standard 25 (Zeiss GmbH, Oberkochen, 
Germany) microscope equipped with a 121-point rect-
angular eyepiece grid (Pyser-SGI Ltd., Edenbridge, 
UK) and a 40 × lens. The well-preserved area of the re-
nal cortex was scanned while noting both the number of 
fields of view and the number of grid cross sections hit-
ting the renal interstitium. Vessels larger than arterioles 
and glomeruli were ignored. The results were expressed 
as the ratio of the points sampled in the interstitium to 
the total number of points sampled in the renal cortex.
The statistical analysis was performed with Sta-
tistica 10 (StatSoft Inc., Tulsa, OK, USA). The 
Mann-Whitney U test was used, while correlations 
were measured by Spearman’s method. The level of 
significance was set at 0.05.
Results
The mean age of all the patients was 37.52 ±13.83 
years (all values expressed as the arithmetic mean 
± SD), with a range of 19-69 years. For LN class IV, 
the mean age was 32.65 ±10.53, while in MPGN it 
was 42.9 ±15.18 years. The mean age for females 
was 35.17 ±12.41 years and 42.35 ±15.61 years for 
males. These differences were statistically significant.
The mean creatinine serum level was 99.45 
±52.18 μmol/l, with a range of 34-310 μmol/l. In 
lupus nephritis class IV, the mean creatinine level was 
87.3 ±38.53 μmol/l, and in MPGN it was 113.84 
±62.51 μmol/l. The mean daily proteinuria level was 
4.77 ±3.19 g/d, with a range of 0.11 to 14.5 g/d. 
In lupus nephritis class IV, the mean daily protein-
uria was 4.67 ±3.45 g/d and in MPGN it was 4.89 
±2.93 g/d. The differences between the groups were 
statistically non-significant.
In both groups the mean relative interstitial vol-
ume (RIV) was 0.2 ±0.09, with a range of 0.03 to 
0.47. In class IV of lupus nephritis, the mean RIV 
was 0.19 ±0.08 and in MPGN the mean RIV was – 
0.22 ±0.1. The differences between the groups were 
statistically non-significant.
The mean count of chymase-positive MCs was 
21.94 ±22.88 per 10 high power fields, while the 
mean count for tryptase-positive MCs was 34.94 
±29.29. The average ratio of chymase-positive to 
tryptase-positive cells was 0.69 ±0.39.
The differences between groups in chymase-pos-
itive and tryptase-positive cell counts were statisti-
cally significant (p < 0.000047 and p < 0.000028, 
respectively). The differences in the ratio of chy-
mase-positive to tryptase-positive cells between 
groups were not significant; however, there was 
a significant negative correlation between the ratio 
of chymase-positive to tryptase-positive cells and 
the chymase-positive cell count (R = –0.36). Chy-
mase-positive MC counts and tryptase-positive MC 
counts were strongly correlated (R = 0.8). Both chy-
mase-positive MC counts and tryptase-positive MC 
LN IV – lupus nephritis class IV; MPGN – membranoproliferative glomerulone-
phritis; central point is median; box is 25-75% range; whiskers are minimum–
maximum values 
Fig. 3. Number of chymase positive cells in lupus nephritis 
class IV and membranoproliferative glomerulonephritis
LN IV – lupus nephritis class IV; MPGN – membranoproliferative glomeruloneph-
ritis; central point is median; box is 25-75% range; whiskers are minimum–ma-
ximum values 
Fig. 4. Number of tryptase positive cells in lupus nephritis 
class IV and membranoproliferative glomerulonephritis
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counts correlated with RIV (R = 0.35 and R = 0.28, 
respectively) and with creatinine level (R = 0.35 and 
R = 0.43, respectively). There was also a significant 
correlation between age and creatinine level and RIV 
(R = 0.28 and R = 0.26, respectively). There was no 
significant correlation with proteinuria.
Discussion
Systemic lupus erythematosus class IV and MPGN 
are two entities differing in etiology and biology, but 
in some cases they share a similar morphologic pat-
tern. In our study we examined the relationship be-
tween the type of renal disease and number of MCs 
found in the renal tissue. Interestingly, more mast 
cells were seen in MPGN than in LN class IV, both 
for chymase-positive and tryptase-positive mast cells. 
Additionally, the counts of mast cells correlated with 
relative interstitial volume (RIV), which confirms the 
role of mast cells in renal interstitial fibrosis.
Membranoproliferative glomerulonephritis displays 
a pattern of glomerular injury seen in both idiopath-
ic forms and secondary diseases associated with sys-
temic or infectious disorders such as hepatitis C or 
LN. The pathogenesis of MPGN is complex and not 
clearly understood. The pathogenesis is thought to 
be different in each subtype of MPGN, but the com-
plement system is significantly involved in all types 
regardless. Type I is probably due to the accumula-
tion of circulating immune complexes which trigger 
the complement cascade via the classical pathway. In 
MPGN type II, the complement system is activat-
ed by the alternative pathway, due to the activity of 
C3 nephritic factor (C3NeF); this IgG autoantibody 
prevents the inactivation of C3 convertase (C3bBb) 
of the alternative pathway, resulting in the break-
down of C3. In type III, the primary role is played 
by slow-acting nephritic factor (NeFt), which stabi-
lizes the properdin-dependent C5 convertase (Cb3) 
2BbP, activating the terminal pathway [3, 4]. Like in 
other types of primary glomerulonephritis, the glo-
merular lesions lead to renal interstitial inflammation 
and fibrosis, culminating in renal failure [10]. Lupus 
nephritis is basically an immune complex disease; 
activation of the complement pathway is also pres-
ent. In SLE class IV, deposits are located mostly in 
the subendothelial and mesangial areas, where they 
activate other renal cells to release proinflammatory 
mediators, leading to interstitial inflammation and 
tissue remodeling [16]. Also key to the pathogenesis 
of SLE is the infiltration of immune cells, consisting 
of B-cells, T-cells, macrophages, dendritic cells and 
mast cells [17-22]. The number of mast cells found 
in the kidney increases in renal diseases, namely di-
abetic nephropathy, acute renal allograft rejection, 
IgA nephropathy, amyloid, renovascular ischemia, 
reflux nephropathy, polycystic kidney disease and 
drug-induced nephropathy [7, 10].
Little information is available with regards to the 
role of mast cells in LN and membranoproliferative 
glomerulonephritis and to the contribution of these 
cells to the pathogenesis of these diseases. 
Togawa et al. investigated chymase expression in 
renal biopsies from children with inter alia MPGN. 
The study showed that the number of chymase-pos-
itive mast cells correlates with the mean intensity of 
the interstitial fibrosis, which is similar to the results 
obtained in our study [12].
Danilewicz et al. analyzed the relationship between 
mast cell count and the expression of interstitial al-
pha-smooth muscle actin (SMA), along with the inter-
stitial inflammatory infiltrates in MPGN type I. They 
found significant positive correlations between inter-
stitial tryptase positive cells and interstitial expression 
of SMA, interstitial volume, serum creatinine as well 
as CD 43+ and CD 68+ cells, which suggests the 
role of MCs in the development of interstitial fibrosis 
[23]. The same group conducted an analogous study 
with rebiopsied patients with MPGN, where they ob-
tained similar results [24]. Danilewicz et al. demon-
strated in another study that the number of interstitial 
tryptase-positive cells was significantly higher in class 
V lupus nephritis than in idiopathic membranous glo-
merulopathy. Both groups exhibited significant posi-
tive correlations between mast cell count and relative 
interstitial volume (RIV), along with serum creatinine 
level [25]. In our study, more mast cells were seen in 
MPGN than in LN. In our present and previous stud-
ies [26], we have found the same positive correlation 
with RIV and creatinine level. Hiromura et al. ex-
amined the number of interstitial mast cells in both 
MPGN and LN. They found a correlation between 
mast cell count, interstitial fibrosis, creatinine level 
and leukocyte infiltration, but not with urinary pro-
tein excretion; the same results were obtained in our 
study. In our previous study, we found that mast cell 
counts differ across classes of SLE, which suggests that 
these cells play a role in the pathogenesis of LN [26].
We have shown that despite the similar pattern of 
pathological changes in the renal glomerulus in LN 
class IV and MPGN, the quantity of mast cells in the 
renal interstitium is different. We also confirmed that 
mast cells contribute to the tubulointerstitial fibrosis, 
while their numbers correlate with RIV. This necessi-
tates further investigation to explain the role of mast 
cells in the pathogenesis of and MPGN.
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